mToR inhibitors-induced proteinuria: mechanisms, significance, and management
- 14 March 2008
- journal article
- review article
- Published by Elsevier BV in Transplantation Reviews
- Vol. 22 (2), 125-130
- https://doi.org/10.1016/j.trre.2007.12.001
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus‐based therapy: a multivariate analysis of results at five years1Clinical Transplantation, 2007
- Sirolimus Does Not Reduce Receptor-Mediated Endocytosis of Albumin in Proximal Tubule CellsTransplantation, 2007
- Differences in Proteinuria and Graft Function in De Novo Sirolimus-Based vs. Calcineurin Inhibitor-Based Immunosuppression in Live Donor Kidney TransplantationTransplantation, 2006
- A Prospective, Open-Label Trial of Sirolimus in the Treatment of Focal Segmental GlomerulosclerosisClinical Journal of the American Society of Nephrology, 2006
- Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathyKidney International, 2005
- Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimusNephrology Dialysis Transplantation, 2005
- Sirolimus‐Induced Thrombotic Microangiopathy is Associated with Decreased Expression of Vascular Endothelial Growth Factor in KidneysAmerican Journal of Transplantation, 2005
- Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimusTransplant International, 2005
- Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathiesNephrology Dialysis Transplantation, 2004
- Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-upTransplant International, 2002